The distribution of lesions reported in addition to concurrent hand eczema included the following: the face (5/13), trunk (3/13), forearms/arms (3/13), flexural surfaces (3/13), feet (2/13), lips (1/13), and insulin pump infusion site (1/13). This evidence concerns the gene INS and hand eczema.